ATE110074T1 - Quinolyloxazol-2-one, nützlich als proteinkinase- c-inhibitoren. - Google Patents

Quinolyloxazol-2-one, nützlich als proteinkinase- c-inhibitoren.

Info

Publication number
ATE110074T1
ATE110074T1 AT89118016T AT89118016T ATE110074T1 AT E110074 T1 ATE110074 T1 AT E110074T1 AT 89118016 T AT89118016 T AT 89118016T AT 89118016 T AT89118016 T AT 89118016T AT E110074 T1 ATE110074 T1 AT E110074T1
Authority
AT
Austria
Prior art keywords
quinolyloxazole
inhibitors
useful
protein kinase
kinase
Prior art date
Application number
AT89118016T
Other languages
English (en)
Inventor
Winton Dr Jones
George P Claxton
Phillip J Robinson
Richard C Dage
Hsien C Cheng
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Application granted granted Critical
Publication of ATE110074T1 publication Critical patent/ATE110074T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
AT89118016T 1988-10-24 1989-09-28 Quinolyloxazol-2-one, nützlich als proteinkinase- c-inhibitoren. ATE110074T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/261,435 US4886811A (en) 1988-10-24 1988-10-24 Qunolyloxazole-2-ones useful as proteinkinase C inhibitors

Publications (1)

Publication Number Publication Date
ATE110074T1 true ATE110074T1 (de) 1994-09-15

Family

ID=22993289

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89118016T ATE110074T1 (de) 1988-10-24 1989-09-28 Quinolyloxazol-2-one, nützlich als proteinkinase- c-inhibitoren.

Country Status (21)

Country Link
US (1) US4886811A (de)
EP (1) EP0365863B1 (de)
JP (2) JP2879454B2 (de)
KR (1) KR0162637B1 (de)
CN (1) CN1025854C (de)
AR (1) AR246733A1 (de)
AT (1) ATE110074T1 (de)
AU (1) AU613302B2 (de)
CA (1) CA2000804C (de)
DE (1) DE68917556T2 (de)
DK (1) DK461389A (de)
ES (1) ES2061863T3 (de)
FI (1) FI93112C (de)
HU (1) HUT58088A (de)
IE (1) IE893011L (de)
IL (1) IL91788A (de)
NO (1) NO894210L (de)
NZ (1) NZ230718A (de)
PH (1) PH27450A (de)
PT (1) PT91870B (de)
ZA (1) ZA897259B (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5036093A (en) * 1987-10-09 1991-07-30 Du Pont Merck Pharmaceutical Aminomethyl oxooxazolidinyl azacycloalkylbenzene derivatives useful as antibacterial agents
DE3907414A1 (de) * 1989-03-08 1990-09-13 Hoechst Ag Die anwendung inhalierter schleifendiuretika zur behandlung von allergen-induzierten nasalen reaktionen
US5190957A (en) * 1989-11-13 1993-03-02 Merrell Dow Pharmaceuticals Inc. Treatment of multi-drug resistant tumors with quinolyl-and isoquinolyloxazole-2-ones
ZA908936B (en) * 1989-11-13 1991-09-25 Merrell Dow Pharma Treatment of multi-drug resistant tumors with quinolyloxazole-2-ones
US5182293A (en) * 1989-11-13 1993-01-26 Merrell Dow Pharmaceuticals Inc. Treatment of multi-drug resistant tumors with pyridyloxazole-2-ones
PH27309A (en) * 1989-11-13 1993-05-28 Merrell Dow Pharma Prevention of glycoprotein enveloped virus infectivity by quinolyl-and isoquinolyloxazone-2-ones
US6515009B1 (en) 1991-09-27 2003-02-04 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US5811447A (en) * 1993-01-28 1998-09-22 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US6395494B1 (en) 1993-05-13 2002-05-28 Neorx Corporation Method to determine TGF-β
US6491938B2 (en) 1993-05-13 2002-12-10 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US6663881B2 (en) 1993-01-28 2003-12-16 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US5981568A (en) 1993-01-28 1999-11-09 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
EP0710116B1 (de) * 1993-05-13 2008-09-03 Poniard Pharmaceuticals, Inc. Prävention und behandlung von pathologien, die mit einer abnormalen proliferationglatter muskelzellen verbunden sind
GB9819382D0 (en) 1998-09-04 1998-10-28 Cerebrus Ltd Chemical compounds I
GB9929216D0 (en) * 1999-12-11 2000-02-02 Univ Bristol Isoquinoline and Quinoline Containing substances
US6613083B2 (en) 2001-05-02 2003-09-02 Eckhard Alt Stent device and method
WO2006130090A1 (en) * 2005-06-03 2006-12-07 Pronas Pharma Ab Use of a substance which inhibits endothelin type b and 5-hydroxytryptamine type 1b receptor upregulation in the treatment of ischemic disorders

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3025215A (en) * 1959-07-29 1962-03-13 Monsanto Chemicals Bis (8-quinolyl carbonate) derivatives
US3857877A (en) * 1973-01-12 1974-12-31 Karamchand Premchand Private 8-hydroxy quinoline derivatives
US4565820A (en) * 1980-07-28 1986-01-21 Pfizer Inc. Hypoglycemic 5-pyrrolyl, indolyl and quinolyl substituted oxazolidine-2,4-diones and their use
GB8505492D0 (en) * 1985-03-04 1985-04-03 Roussel Lab Ltd Chemical compounds
US4738972A (en) * 1985-05-21 1988-04-19 Pfizer Inc. Hypoglycemic thiazolidinediones
US4673680A (en) * 1985-09-18 1987-06-16 Pendleton Robert G α2 -adrenergic receptor antagonists as modifiers of gastrointestinal motility
US4698353A (en) * 1985-11-13 1987-10-06 Merrell Dow Pharmaceuticals Inc. Cardiotonic heterocyclic oxazolones
US4728661A (en) * 1985-11-13 1988-03-01 Merrell Dow Pharmaceuticals Inc. Cardiotonic phenyl oxazolones
US4670450A (en) * 1985-11-13 1987-06-02 Merrell Dow Pharmaceuticals Inc. Cardiotonic thiazolones
US4681940A (en) * 1985-11-19 1987-07-21 American Home Products Corporation 5-[3-[[2-quinolyl]methoxy]phenyl]-1,3-oxazoles
JP6128676B2 (ja) 2013-01-29 2017-05-17 株式会社チノー 電力調整器

Also Published As

Publication number Publication date
PT91870A (pt) 1990-04-30
FI894459A0 (fi) 1989-09-20
IL91788A0 (en) 1990-06-10
KR900006307A (ko) 1990-05-07
DE68917556D1 (de) 1994-09-22
FI93112C (fi) 1995-02-27
JP2983970B2 (ja) 1999-11-29
PT91870B (pt) 1995-05-31
JPH11152285A (ja) 1999-06-08
ES2061863T3 (es) 1994-12-16
US4886811A (en) 1989-12-12
NO894210D0 (no) 1989-10-23
DK461389D0 (da) 1989-09-19
AU613302B2 (en) 1991-07-25
AU4249389A (en) 1990-04-26
CN1025854C (zh) 1994-09-07
JP2879454B2 (ja) 1999-04-05
CA2000804C (en) 1999-04-06
ZA897259B (en) 1990-07-25
EP0365863B1 (de) 1994-08-17
NO894210L (no) 1990-04-25
FI894459A7 (fi) 1990-04-25
FI93112B (fi) 1994-11-15
DK461389A (da) 1990-04-25
KR0162637B1 (ko) 1998-12-01
AR246733A1 (es) 1994-09-30
EP0365863A3 (en) 1990-11-07
IE893011L (en) 1990-04-24
CA2000804A1 (en) 1990-04-24
EP0365863A2 (de) 1990-05-02
IL91788A (en) 1994-04-12
HU895410D0 (en) 1990-01-28
PH27450A (en) 1993-07-02
JPH02164878A (ja) 1990-06-25
HUT58088A (en) 1992-01-28
DE68917556T2 (de) 1994-12-15
NZ230718A (en) 1990-11-27
CN1042145A (zh) 1990-05-16

Similar Documents

Publication Publication Date Title
FI893167A0 (fi) Moerk, neutralgrao, nickelfri glaskomposition.
FI895157A0 (fi) Laosanordning foer flyttbara anordningars, saerskilt sjukvaeddars, hjul.
NO900543L (no) Fremgangsmaate for retningsbestemmelse i borehull.
FI893644L (fi) Tetrahydro-1-benz-/c,d/ -indolpropionsyrasulfonamider.
FI891096A7 (fi) Genomskinligt, sjaelvbaerande skarvstycke foer byggnadskonstruktioner.
ATE121741T1 (de) Piperidinyl-benzimidazole als antihistaminica.
FI892117A0 (fi) Enskiktigt, soemmat pappersmaskintyg.
FI902898A0 (fi) Lutningskompensator foer snabbgaoende fordon, saerskilt raelsfordon.
ATE110074T1 (de) Quinolyloxazol-2-one, nützlich als proteinkinase- c-inhibitoren.
FI891713L (fi) Slangskal, speciellt konstgjort korvskal med limband i laengsaxelriktningen.
FI882607L (fi) Flyttbart, sjaelvhaeftande skrivark.
FI894892A0 (fi) Koppling foer fluidledningar, speciellt snabbkoppling.
FI893791A7 (fi) Oeverfoerlaengbar, tredelad teleskopisk ledare.
FI890827A7 (fi) Lysyloxidas-inhibitorer.
FI896346A0 (fi) Organiska, svavelhaltiga foereningar foer anvaendning i positiva, elektrostatiska, vaetskeformiga framkallningsmedel.
FI896345A0 (fi) Bipolaert, vaetskeformigt, elektrostatiskt framkallningsmedel.
FI893450L (fi) Modifierade proteiner.
FI892163A7 (fi) Valsanordning, saerskilt kalander.
NO892244L (no) Fremgangsmaate til immundiagnostisk bestemmelse.
FI893211A0 (fi) Antihypertensiva, n-terminala eteraminodiolamino-syraderivat.
FI895500A0 (fi) Ledning, inklusive drivanordning foer pappers- eller kartongbanor.
FI890987A7 (fi) Tryckanordning, saerskilt tryckanordning foer resebiljetter.
FI891507L (fi) Staell foer solfaongare.
IT8919815A0 (it) Compasso, particolarmente per disegnatori.
FI892822A0 (fi) Ljuskaensliga, negativt arbetande offsettryckplattor.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee